Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced a partnership with actor, comedian and advocate, Will Forte, to increase awareness of Huntington's ...

Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...

Smith ⁠Drug asked the court for an unspecified amount of monetary damages on behalf of a proposed class of Victoza purchasers ...

Drug companies have announced a slew of deals for tools to unleash the promise of AI, seen as the biggest technological ...

Novo Nordisk (NVO) faces a class action suit over claims it ran a pay-for-delay deal with Teva (TEVA) to delay generics for its diabetes drug Victoza. Read more here.

Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...

Novo Nordisk AS was sued in federal court Friday with allegations that it monopolized the blockbuster weight loss medication Victoza through an illegal deal with a competitor to delay the generic, ...

Danish pharmaceutical giant Novo Nordisk was hit with a class action lawsuit in New York federal court on Friday for allegedly misusing its patents to maintain a monopoly on its diabetes drug Victoza.

The cash injection will also allow Corxel to start phase 2 testing in type 2 diabetes and help to fund a phase 3 programme in ...

Get all latest & breaking news on Teva Pharmaceuticals. Watch videos, top stories and articles on Teva Pharmaceuticals at moneycontrol.com.

As Sandoz looks to address the “biosimilar void” created by the scores of lucrative drugs going off patent in the next decade ...